PHIA Koninklijke Philips N.V.

Philips and Vietnamese Hong Duc General Hospital sign multi-year strategic partnership agreement

Philips and Vietnamese Hong Duc General Hospital sign multi-year strategic partnership agreement

11 April 2019

  • Philips to provide turnkey hospital solution to newly-built Hong Duc General Hospital II, including the latest medical imaging and healthcare IT solutions as well as design, consulting and financing services
  • Starting in early 2020, Hong Duc General Hospital II will provide a full range of general healthcare services to serve the growing healthcare needs of Ho Chi Minh City

Amsterdam, the Netherlands and Ho Chi Minh City, Vietnam – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Hong Duc General Hospital in Ho Chi Minh City in Vietnam today announced a seven-year partnership agreement covering a comprehensive turnkey solution for high quality general healthcare services. Philips will provide the newly-built Hong Duc General Hospital II with the latest medical imaging, patient monitoring and healthcare IT solutions. In addition, Philips will deliver comprehensive training programs to strengthen the hospital’s clinical capabilities and design services to optimize workflows and enhance the patient/staff experience, with the aim of delivering better clinical outcomes.

Hong Duc General Hospital is one of the most trusted healthcare providers in Ho Chi Minh City, with hundreds of thousands of admissions annually. Scheduled to open in early 2020 to cope with increasing patient demands, the newly-built Hong Duc General Hospital II will provide high quality general healthcare services, especially focused on cardiology, oncology, orthopedics and pediatrics.

Minimally-invasive heart valve replacement

The hospital’s hybrid operating room will be equipped with Philips’  advanced Azurion image-guided therapy platform for both routine and complex interventional procedures such as transcatheter aortic valve implantation (TAVI) and spine surgery. The hospital will also be provided with connected patient monitoring and  integrated analytics solutions from Philips, enabling the continuous monitoring of patients wherever they are in the system – from the ambulance and functional examination departments to the ICU and general wards – providing a comprehensive solution during the entire treatment and recovery process.



“As a leading health technology company, Philips provides meaningful innovations in collaboration with medical partners to deliver value-based healthcare,” said Hugo Luik, General Manager, Philips Vietnam. “By providing advanced, well-maintained medical technology and solutions, Philips aims to improve health outcomes for people in Vietnam, enhancing the patient experience, improving staff satisfaction, reducing stress among care providers, and lowering the cost of care.”

“Hong Duc General Hospital’s objective has always been to provide patients with the best quality of healthcare, with the support of the most advanced medical technology,” said Huynh Thi Kim Loan, President of Hong Duc General Hospital. “Our partnership with Philips is aimed at building Hong Duc General Hospital II as a ‘smart hospital’, where our experts and doctors are more confident to make clinical decisions supported by Philips’ latest health technologies. Patients can be assured that the most advanced quality of healthcare is delivered at Hong Duc General Hospital.”



Other solutions provided to the hospital by Philips include Philips’ Digital Ingenia 3.0T MRI with High-Intensity Focused Ultrasound (MR-HIFU), and advanced CT technology with high resolution and low-dose scanning. The MR-HIFU solution at Hong Duc General Hospital II will provide a non-invasive alternative to the traditional surgical treatment of uterine fibroids and enable non-invasive palliative pain treatment for bone metastases.

For further information, please contact:

Joost Maltha

Philips Group Press Office

Tel: 6

E-mail:



Elaine Ng

Philips ASEAN Pacific

Tel.:

E-mail:



About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

About Hong Duc General Hospital

Established in September 2000, Hong Duc General Hospital is one of the most trusted healthcare providers in Ho Chi Minh City with hundreds of thousands of admissions annually. It has more than 5,000 inpatients and performs 2,000 laparoscopies per year. The hospital has gained many achievements in terms of patient outcome, investment in advanced healthcare equipment, and lower costs. The establishment of Hong Duc II and III Hospital aims at meeting social demands in healthcare service. For more information, please visit

 

Attachment

EN
11/04/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: RDOS. 4T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADELL...

Rdos. 4T’25 vs 4T’24: Ventas: 5.097 M euros (+1,1% vs -0,9% BS(e) y -1,0% consenso); EBITA Aj.: 770 M euros (+13,4% vs +0,6% BS(e) y -1,0% consenso); BDI: 397 M euros (-333 M euros en 2024 vs 275 M euros BS(e) y 276 M euros consenso); Rdos. 2025 vs 2024: Ventas: 17.834 M euros (-1,0% vs -1,6% BS(e) y -1,6% consenso); EBITA Aj.: 2.195 M euros (+5,7% vs +1,5% BS(e) y +1,0% consenso); BDI: 897 M euros (-698 M euros en 2024 vs 775 M euros BS(e) y 776 M euros consenso).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch